Registered entities
Cara Therapeutics, Inc.
Reg. No. 1346830United States
CARA THERAPEUTICS, INC
Reg. No. 75-3175693United States
Cara Therapeutics, Inc.
Reg. No. 001t000000WnJrfAAFUnited States
Cara Therapeutics Inc
Reg. No. 753175693United States
Innovation
33 patent families (18 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,668 times.
| Year | Filings |
|---|---|
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 3 |
Investor mix
9 investors on record; lead investors include Rho Capital Partners, SWIP; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Private equity | 2 | 22% |
| Other / undisclosed | 1 | 11% |